TCT-329 Two-Year Outcomes of Cobalt Chromium Everolimus-Eluting Stents for the Treatment of In-Stent Restenosis: An Updated Analysis of the ILUMIEN IV Trial
JACC · 2026-11 · 88 (18) · B141
DOI: 10.1016/j.jacc.2026.09.428 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Ziad Ali und 18 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ali, Z., Shin, D., Kakehi, K., Rao, A., Maehara, A., Matsumura, M., Shlofmitz, E., Calligaris, G., Maksoud, A., Abdelwahed, Y., Gonzalo, N., Alfonso, F., Fall, K. N., Chehab, B., Nie, H., Wang, J., Buccola, J., Landmesser, U., & Stone, G. (2026). TCT-329 Two-Year Outcomes of Cobalt Chromium Everolimus-Eluting Stents for the Treatment of In-Stent Restenosis: An Updated Analysis of the ILUMIEN IV Trial. JACC, 88(18), B141. https://doi.org/10.1016/j.jacc.2026.09.428
Vancouver
Ali Z, Shin D, Kakehi K, Rao A, Maehara A, Matsumura M, et al. TCT-329 Two-Year Outcomes of Cobalt Chromium Everolimus-Eluting Stents for the Treatment of In-Stent Restenosis: An Updated Analysis of the ILUMIEN IV Trial. JACC. 2026;88(18):B141. doi:10.1016/j.jacc.2026.09.428
BibTeX
@article{Ali2026,
author = {Ali, Ziad and Shin, Doosup and Kakehi, Kazuyoshi and Rao, Ava and Maehara, Akiko and Matsumura, Mitsuaki and Shlofmitz, Evan and Calligaris, Giuseppe and Maksoud, Aziz and Abdelwahed, Youssef and Gonzalo, Nieves and Alfonso, Fernando and Fall, Khady N. and Chehab, Bassem and Nie, Hong and Wang, Jin and Buccola, Jana and Landmesser, Ulf and Stone, Gregg},
title = {TCT-329 Two-Year Outcomes of Cobalt Chromium Everolimus-Eluting Stents for the Treatment of In-Stent Restenosis: An Updated Analysis of the ILUMIEN IV Trial},
journal = {JACC},
year = {2026},
volume = {88},
number = {18},
pages = {B141},
doi = {10.1016/j.jacc.2026.09.428}
}
EUVIMED